EZH2

Junk DNA. Illustration: depositphotos.com

“Junk DNA” offers surprising treatment directions for resistant blood cancer

Researchers at King's College London have identified a promising strategy for treating some blood cancers by repurposing existing drugs, targeting a region of the human genome previously considered "junk DNA."